Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia EP News Bureau Aug 1, 2019 Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…
